Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varilrix immunogenicity in autologous stem cell transplant recipients
NCT00792623Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2003
- Primary completion
- Sep 2007
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of varicella virus vaccine live in varicella (VZV), sponsored by GSK. Primary endpoints: Number of Subjects With a Varicella Vaccine Response and Anti-varicella Zoster Virus (Anti-VZV) Antibody Titers. Started Sep 2003; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT00792623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00792623.